Radioactive stents - Problems and potential solutions;Radioaktive stents - Problematik und lösungsmöglichkeiten

Herz

Volumn 27, Issue 1, 2002, Pages 17-22

  Hehrlein, Christoph ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Angiopasty; Coronary stent; Restenosis

Indexed keywords

RADIOACTIVE MATERIAL;

ANGIOPLASTY; BRACHYTHERAPY; CATHETERIZATION; CELL PROLIFERATION; CORONARY STENT; DRUG COATING; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; RESTENOSIS; REVIEW;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBIOTICS, ANTINEOPLASTIC; BRACHYTHERAPY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PHOSPHORUS RADIOISOTOPES; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS; SIROLIMUS; STAINLESS STEEL; STENTS;

EID: 18244401414     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-2338-0     Document Type: Review

References (31)

1. Coumarin and aspirin in the prevention of restenosis recurrence after percutaneous transluminal coronary angioplasty: A randomized study
2. Restenosis after successful coronary angioplasty in patients with single-vessel disease
3. Emergency stenting for acute occlusion after coronary balloon angioplasty
4. A comparison of ballon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
5. Relative risk analysis of angiographic predictors of restenosis within the coronary Wallstent
6. Hoop dreams. Stents without restenosis
7. Radioactive coronary stent implantation inhibits neointimal proliferation in nonatherosclerotic rabbits
8. History of the radioisotope stent
9. Influence of surface texture and charge on the biocompatibility of endovascular stents
10. The radioactive stent
11. Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits
12. Pure beta-particle-emitting stents inhibit neointima formation in rabbits
13. Advantages and limitations of radioactive stents
14. Increased apoptotic cell death in the neointima after stent-based vascular irradiation. Role of radiation-induced apoptosis for restenosis reduction
15. Update on radioactive stents
16. The impact of stent design and delivery upon the long term efficacy of radioisotope stents
17. P32 stents for the prevention of restenosis. Results from the Heidelberg safety trial using the Palmaz-Schatz stent design at moderate activity levels in patients with restenosis after PTCA
18. 32P radioactive stents is caused by the combination of chronic stent injury and radioactive dose falloff
19. Intravascular ultrasound (IVUS) analysis of β-particle radioactive stent implantation in human coronary arteries. Preliminary immediate and intermediate-term results of the MILAN study
20. Short-and intermediate-term results of 32P radioactive β-emitting stent implantation in patients with coronary artery disease
21. Edge restenosis after implantation of high activity 32P radioactive β-emitting stents
22. Beta-particle emitting radioactive stent implantation: A safety and feasibilty study
23. 32P radioactive stent
24. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro
25. 103Pd) stent to prevent edge effects
26. Endovascular stent design dictates experimental restenosis and thrombosis
27. 32p radioactive self-expanding nitinol stent
28. Bench to bedside: The development of rapamycin and its application to stent restenosis
29. Lack of neointimal proliferation after implantation of sirolimus-coated stent in human coronary arteries. A quantative coronary angiography and three-dimensional intravascular ultrasound study
30. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up
31. Living the dream of no restenosis